Pfizer deal with Seagen

Pharmaceutical giant Pfizer Inc. (PFE.N) has announced its intention to acquire Seagen Inc. (SGEN.O) in a $43 billion deal. The acquisition is aimed at reinforcing Pfizer's portfolio of targeted cancer therapies in the face of an expected decline in sales...